As telehealth continues to grow, there are a number of legal, regulatory, and operational issues that threaten to stall its progress. We have tackled many of these issues in previous blog posts. But no obstacle looms larger than the issue of payment. How can providers get consistently and appropriately reimbursed by payers for use of telehealth? Absent a clear answer, telehealth will likely find it difficult to fulfill its great promise—at least in the United States. Other countries are pulling ahead. Here is a look at the current reimbursement landscape facing providers and what ...
Blog Editors
Recent Updates
- Watch: FDA’s 2026 Enforcement Priorities: What In-House Counsel Must Know – Thought Leaders in Health Law
- The Future of 340B: New Bills Offer Competing Solutions to Modernize the 340B Drug Discount Program
- "Enough Is Enough": HHS-OIG Freezes Funds for New York Medicaid Fraud Control Unit, Effective July 1
- Straight From the Source: AHLA Annual Meeting Highlights Fraud and Abuse Enforcement Efforts in 2026 and Beyond
- At the Half: No Free Kicks in FDA’s 2026 Enforcement